MYC and breast carcinoma: Our results demonstrated that in breast cancer, high AIMP2 expression was predominantly found in MTORC1 signaling, MYC TARGETS_V2, UNFOLDED_ PROTEIN_RESPONSE, and other signaling pathways (Fig. 7A).